Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis

Back

HFA Premium Access

Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 6

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor R. Rascon Sabido (Veracruz, MX)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)

1 presentation

0 follower

7 more presentations in this session

Divergent clinical trajectories in heart failure: clinical profiles and outcomes in reduced versus preserved ejection fraction patients

Speaker: Doctor J. Hurtado Cordova (Tlalpan, MX)

Unlocking SGLT2 inhibitors: evaluating elderly HFrEF patients with and without T2DM

Speaker: Mrs H. Ismail (Kuala Lumpur, MY)

Endothelial dysfunction and hospitalization risk in heart failure with reduced ejection fraction: insights from microvascular reactivity assessment

Speaker: Doctor S. Charfeddine (Sfax, TN)

Access

Abstract

Slides

Links between abnormal exercise parameters and diastolic dysfunction in heart failure with reduced ejection fraction

Speaker: Doctor A. Attanasio (San Donato Milanese, IT)

Echocardiographic characteristics of patients with CpcPH, and IpcPH in HFrEF, Insight of PHHF study. Insight of PHHF study

Speaker: Doctor E. Berthelot (Le Kremlin-Bicetre, FR)

Access the full session

ePosters in chronic heart failure - pathophysiology and mechanisms 6

Speakers: Doctor R. Rascon Sabido, Doctor J. Hurtado Cordova, Mrs H. Ismail, Doctor S. Charfeddine, Doctor A. Attanasio...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources